about
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-AmericansThe evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio.The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.Genetic effects influencing risk for major depressive disorder in China and Europe.Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.Characterization of genetic variation in the VGLL4 gene in anorexia nervosa.Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.KCNJ6 is associated with adult alcohol dependence and involved in gene × early life stress interactions in adolescent alcohol drinking.αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans.Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.Major depressive disorder and current psychological distress moderate the effect of polygenic risk for obesity on body mass index.Genetic and Environmental Risk for Chronic Pain and the Contribution of Risk Variants for Major Depressive Disorder: A Family-Based Mixed-Model AnalysisPolygenic risk for alcohol dependence associates with alcohol consumption, cognitive function and social deprivation in a population-based cohort.Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsHPA-axis activity in alcoholism: examples for a gene-environment interaction.Gene-environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1.Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European AmericansAssociation study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.The genetics of alcoholism.Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts.Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort.Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766).OPRD1 Genetic Variation and Human Disease.Risk and protective factors for structural brain ageing in the eighth decade of life.Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank.Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117).Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.Multiple polymorphisms in genes of the adrenergic stress system confer vulnerability to alcohol abuse.An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population.Genome-wide haplotype-based association analysis of major depressive disorder in Generation Scotland and UK Biobank.Genome-wide meta-analyses of stratified depression in Generation Scotland and UK Biobank.Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism.Cohort Profile: Stratifying Resilience and Depression Longitudinally (STRADL): a questionnaire follow-up of Generation Scotland: Scottish Family Health Study (GS:SFHS).Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-induced alcohol drinking.Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans.Addendum: Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways
P50
Q30543145-1C640C7A-CDB7-424F-A8EC-70A5C2E31AB5Q33282314-AEFC0361-80DE-4A02-81D2-6F6B8109E2A7Q33579769-1EA28257-6622-43A0-AE3D-54302A659E64Q33601878-CEA9F84C-E4E0-48AB-978A-11450BA9C0F2Q33635647-CA45A05E-FD1F-4A62-B03B-352E3A60FE5CQ33923747-8D9680AB-E98D-4732-B7EC-E530E52220D4Q34330604-55375310-8981-4524-8E3F-EA986A03C1CCQ34820222-15ADC3B7-6C44-4C0D-86FC-87ED721F21C9Q35150218-F51592DB-4259-4F27-82C5-345CC3A453D7Q35571722-4CA0C730-32AF-454F-99EB-20F25CE3454EQ35813174-B2BD8A83-DE49-49B0-93D6-7A8435B4519EQ36104781-E1A8DE47-C94C-4938-A9CE-453536EBE593Q36144650-67AB2DFE-27C2-4F2C-8DFF-4A19278E5C30Q36431241-7435640E-8E4C-4EFC-ADF1-71BDE325942FQ36958010-94DF55EE-DB32-4A13-977E-848114205940Q37467170-3EF41DF2-51CF-4AD1-B841-CED691F1E7FEQ37492566-66602293-4DB8-459E-A436-4D445A460E7CQ37576232-9D5D9AD6-DD1D-4C81-8BD9-D3D1763ED2F7Q37604495-E27C6A09-292A-42A4-B8CD-55996CDEC18DQ37648248-D4073539-F15A-465D-94DE-834B24250D7AQ37705283-25B7E6E7-2DC1-42EE-B470-A0421A4CCDFFQ37717808-C156FB58-95D3-4A26-9FDA-0949B8C35619Q38623862-5C242664-8C57-4FD8-88E2-10EADE4B9924Q39051440-DE6A6403-97E5-4D52-BC44-125DC2820BA6Q40235362-EC58605B-8929-47DA-9281-54B916BDFE42Q42361174-49820F6E-EBDC-4D7A-AE86-8A97489CBA9AQ42367819-E022777D-969E-432A-9E42-EB6C91AAFF22Q44022700-D5E0BC5D-113D-462E-A292-D2A2803DE46AQ44246923-EBD06F48-F751-4F3A-BDDE-CEE4A2740A1EQ44341978-B643D7AF-CB6C-4B89-A85B-6206ACD5BF27Q47394982-5F21AE6F-8B39-4F52-8367-EEAF85918DFCQ47556039-CBE5EADE-0A31-4732-94B7-5A15118F46E3Q47562858-FB7353E1-A1B7-4C87-8335-E9E184298DB9Q47736676-D87451E0-A3D7-4ED5-8BFB-AB694D463BFAQ47988659-7CFA8085-E435-48D4-B765-7679293C9197Q48002929-FF148D21-38E3-41A3-B81A-7E54E6FE3071Q51858168-CEFCBD6D-6C67-4542-ADBB-A29E13765EA4Q52584632-87F3C649-86CE-4ADC-8D73-9A63C09BD3B9Q55665082-DEEB563D-0A5D-4D13-A101-BF530963C206Q56992584-283B4C1E-BE6B-481C-858E-CCF648A3BE33
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toni-Kim Clarke
@ast
Toni-Kim Clarke
@en
Toni-Kim Clarke
@es
Toni-Kim Clarke
@nl
Toni-Kim Clarke
@sl
type
label
Toni-Kim Clarke
@ast
Toni-Kim Clarke
@en
Toni-Kim Clarke
@es
Toni-Kim Clarke
@nl
Toni-Kim Clarke
@sl
prefLabel
Toni-Kim Clarke
@ast
Toni-Kim Clarke
@en
Toni-Kim Clarke
@es
Toni-Kim Clarke
@nl
Toni-Kim Clarke
@sl
P106
P31
P496
0000-0002-7745-6351